510(k) Report

510(k) · Cleared

Cleared

Port-a-Cath II Trans-Arterial Percutaneous System

K992697510(k) TraditionalCleared Nov 18, 199999-day reviewClass II21 CFR 880.5965

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sims Deltec, Inc. · LJT Port & Catheter, Implanted, Subcutaneous, Intravascular

Cleared on Nov 18, 1999 as substantially equivalent to K942024 (Pharmacia Deltec, Inc., 1994) and 1 other predicate after a 99-day review. Its family tree reaches back 1 generation to 1983. 3 later devices descend from it.

Decided
Nov 18, 1999
Review
99 days
Class
Class II
Product code
LJT
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K830730 (1983). 2 ancestors in all. 3 later devices descend from it, 2 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1994: 1 other ancestor2006: 1 descendant cleared2004: 1 descendant cleared2013: 1 descendant clearedK830730 · Port-a-Cath Implantable Cath. Sys · Pharmacia, Inc. · 1983 · recalled19801990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 2 descendants2 generations forward: 1 descendant K830730 · Port-a-Cath Implantable Cath. Sys · Pharmacia, Inc. · 1983 · recalled0
  1. Root · 1 generation backK830730 Port-a-Cath Implantable Cath. SysPharmacia, Inc. · 1983 · Recalled
  2. This deviceK992697 Port-a-Cath II Trans-Arterial Percutaneous SystemSims Deltec, Inc. · 1999
  3. Descendant · cites it directly · 1 of its ownK061424 Celsite/ Celsite Concept, Access PortsAesculap, Inc. · 2006 · Recalled
  4. Descendant · 2 generations on · 0 of its ownK130576 Celsite Implantable Access Port SystemsB. Braun Interventional Systems, Inc. · 2013 · Recalled
  5. Descendant · cites it directly · 0 of its ownK033686 Port-a-Cath II Regional Arterial Portal SystemSmiths Medical MD, Inc. · 2004

Most influential descendants

Showing 3 of 3 · See all
  • K061424Celsite/ Celsite Concept, Access PortsAesculap, Inc. · 2006 · cites it directly1descendant
  • K130576Celsite Implantable Access Port SystemsB. Braun Interventional Systems, Inc. · 2013 · 2 generations on0descendants
  • K033686Port-a-Cath II Regional Arterial Portal SystemSmiths Medical MD, Inc. · 2004 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K830730Port-a-Cath Implantable Cath. SysPharmacia, Inc.19831
0 (this device)K992697Port-a-Cath II Trans-Arterial Percutaneous SystemSims Deltec, Inc.1999—
+1K061424Celsite/ Celsite Concept, Access PortsAesculap, Inc.20062
+2K130576Celsite Implantable Access Port SystemsB. Braun Interventional Systems, Inc.20132
+1K033686Port-a-Cath II Regional Arterial Portal SystemSmiths Medical MD, Inc.2004—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
200610
201310
FIG. 1 — Lineage of K992697, 1983–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LJT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LJT device

  1. #1 K251253 PowerPort™ isp Implantable Port; PowerPort™…score 14.9 · 9 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K942024Port-a-Cath Low Profile Implantable Venous Access System
Summary page 2
…ystem PORT-A-CATH® II Low Profile™ System PORT-A-CATH® Arterial System MANUFACTURER SIMS Deltec, Inc. SIMS Deltec, Inc. SIMS Deltec, Inc. 510(K) NUMBER Subject Device K942024 K830730B INDICATIONS FOR A system is indicated A system is indicated A system is indicated USE when a patient requires when a pat…
Pharmacia Deltec, Inc.19948
*K830730Port-a-Cath Implantable Cath. Sys
Summary page 2
…ORT-A-CATH® II Low Profile™ System PORT-A-CATH® Arterial System MANUFACTURER SIMS Deltec, Inc. SIMS Deltec, Inc. SIMS Deltec, Inc. 510(K) NUMBER Subject Device K942024 K830730B INDICATIONS FOR A system is indicated A system is indicated A system is indicated USE when a patient requires when a patient req…
Pharmacia, Inc.19831

Also cleared against K942024: 4 other devices →

What descends from it? (3)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K061424Celsite/ Celsite Concept, Access PortsAesculap, Inc.20061
K033686Port-a-Cath II Regional Arterial Portal SystemSmiths Medical MD, Inc.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • 2 of the 2 ancestors have a recall of any class.
  • Of its descendants, K061424 (Aesculap, Inc., 2006) has gone furthest, with 1 descendant of its own.
  • 4 other devices also cite its predicate K942024.

How does its category compare?

All LJT devices

LJT Port & Catheter, Implanted, Subcutaneous, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LJT

2in 2025

2007: 112008: 72009: 22010: 22011: 52012: 22013: 72014: 22015: 42016: 32019: 12020: 12023: 12024: 12025: 22026 (partial year): 1
2007high 11 (2007) · low 0 (2017)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LJT

182in 2016

2007: 85 days median2008: 119 days median2011: 144 days median2013: 150 days median2015: 164 days median2016: 182 days median
2007high 182 (2016) · low 85 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LJT

1in 2022

2007: 12008: 22009: 22010: 192011: 12012: 22015: 12017: 12018: 12019: 72022: 12026 (partial year): 1, 1 Class I
2007high 19 (2010) · low 0 (2013)2026

Class I (1 since 2007) Class II/III not classified

Adverse event reports per year · LJT

4,308in 2025

2007: 2082008: 1612009: 1722010: 2072011: 2022012: 1532013: 1412014: 1432015: 1492016: 1352017: 2622018: 8782019: 7652020: 9592021: 1,2852022: 1,3342023: 1,2212024: 1,8962025: 4,308
2007high 4,308 (2025) · low 135 (2016)2025

MAUDE reports naming product code LJT, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200711851208
200871192161
20092—2172
20102—19207
201151441202
20122—2153
201371500141
20142—0143
201541641149
201631820135
20170—1262
20180—1878
20191—7765
20201—0959
20210—01,285
20220—11,334
20231—01,221
20241—01,896
20252—04,308
20261—1 (1)—

What is it indicated for?

A system is indicated when a patient requires prolonged or repeated intra-arterial infusion.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K992697: Port-a-Cath II Trans-Arterial Percutaneous System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K992697

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026